About Faraday Pharma
Faraday Pharma is a Healthcare company based in Seattle (United States) founded in 2014. Development of elemental reducing agents is pursued for patient outcomes. Faraday Pharma has raised $115.5 million across 5 funding rounds from investors including ARE, Arch Venture Partners and Polaris Partners. The company has 22 employees. Faraday Pharma offers products and services including FDY-5301. Its focus areas include Diversified Pharmaceuticals. Its legal entity is FARADAY PHARMACEUTICALS, INC.
Company details
Faraday Pharma was founded in 2014 and is headquartered in Seattle, United States. Operations are centered in the biopharmaceutical sector, where elemental reducing agents are developed. These agents leverage reduced forms of elements to enhance patient outcomes. Focus is placed on research and advancement of this approach within the industry.
- Headquarters Seattle, United States
- Employees 22
- SectorsHealthcare
- Website faradaypharma.com
- Social LinkedIn X
- Legal Name Faraday Pharmaceuticals, Inc.
- Total Equity Funding$115.5M (USD)
in 5 rounds
- Latest Funding Round$52.83M (USD), Series B
Nov 2022
- InvestorsARE
& 4 more
- Employee Count22
Products & Services of Faraday Pharma
Faraday Pharma offers a comprehensive portfolio of products and services, including FDY-5301.
Investigational drug to reduce heart attack damage by targeting reperfusion injury.
Funding Insights of Faraday Pharma
Faraday Pharma has successfully raised a total of $115.5M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $52.83 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $115.5M
- Total Rounds 5
- Last Round Series B — $52.83M
- Investors Count 5
All 5 funding rounds of Faraday Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $52.83M | Series B | – | – | – |
| Sep 2019 | $25.07M | Series A | – | – | – |
| Mar 2019 | $5M | Series A | – | – | – |
| Feb 2017 | $32.61M | Series A | – | Arch Venture Partners, Polaris Partners | |
| Jul 2014 | Series A | – | Arch Venture Partners, Polaris Partners |
5 investors in total: 5 institutional.
Investors in Faraday Pharma
Faraday Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Arch Venture Partners and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Early- to growth-stage startups are targeted for venture capital investments. | oup.vc | Bala Cynwyd, United States | ||
Early-stage venture capital is provided to US companies across sectors. | wrfseattle.org | Seattle, United States | ||
REIT that invests in campuses, multi-tenant spaces and build-to-suit facilities in the US | 1994 | are.com | Pasadena, United States |
Investor details for Faraday Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Faraday Pharma
22 people are tracked at Faraday Pharma (13 in leadership, 4 in board & advisors, 5 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Stephen A. Hill | CEO | Leadership |
Ron Kierpa | Chief of Corporate Development | Leadership |
Simon J. Tulloch | CMO | Leadership |
Tressa Randall | VP, Regulatory Affairs | Leadership |
Brian Blackman | CFO | Leadership |
Catherine Hutt | Associate Director, Clinical Operations | Leadership |
Tara Allen | Senior Director Clinical Operations | Leadership |
Shannon Wilson | VP, Clinical Operations | Leadership |
Simon Tulloch, BA MA BM BCh, Medicine | CMO | Leadership |
Ernestine Harte | Director, Quality Assurance | Leadership |
Nicole Quinones | Director, Data Management | Leadership |
Ben Haber | Senior Director, Data Management | Leadership |
Duyen Mai | Senior Director Pharmacovigilance | Leadership |
Steven Gillis | Chairman | Board & advisors |
Lawrence Gozlan | Director | Board & advisors |
Terry McGuire | Director | Board & advisors |
Mark B. Roth | Director | Board & advisors |
Patrick C. Rock | General Counsel & Corporate Secretary | Team |
Serafima Golembo | Senior Associate, Regulatory Operations | Team |
Mary Beth Schornak | Controller | Team |
2 more people are available in the full profile.
Complete people profiles for Faraday Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Faraday Pharma
3 dated milestones of Faraday Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Faraday Pharma is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $52.8M.
Web traffic of Faraday Pharma
Websites that share an audience with Faraday Pharma (faradaypharma.com).
Websites whose visitors overlap most with Faraday Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmain.com | 100% | 1.5K | #11,691,207 | View details | |
| soundpharma.com | 97% | 2.7K | #5,693,412 | View details | |
| talus.bio | 95% | 4.4K | #4,306,649 | View details | |
| omeros.com | 94% | 15.6K | #1,695,799 | View details | |
| alpenglowbiosciences.com | 94% | 3.7K | #4,504,338 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Faraday Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Faraday Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Faraday Pharma
Complete news archive for Faraday Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Faraday Pharma
Faraday Pharma was founded in 2014.
Faraday Pharma is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Faraday Pharma is a funded company, having raised a total of $115.5M across 5 funding rounds to date.
Faraday Pharma has 22 employees.
Faraday Pharma was founded in 2014 and is headquartered in Seattle, United States. Operations are centered in the biopharmaceutical sector, where elemental reducing agents are developed. These agents leverage reduced forms of elements to enhance patient outcomes. Focus is placed on research and advancement of this approach within the industry.
Faraday Pharma offers FDY-5301.
Faraday Pharma has 5 investors. Key investors include ARE, Arch Venture Partners, Polaris Partners, Osage University Partners, and Washington Research Foundation.
Faraday Pharma operates through Faraday Pharmaceuticals, Inc..